Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Anal Biochem ; 612: 113952, 2021 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-32926865

RESUMO

During the development of a specific dipeptidyl peptidase 4 (DPP4) inhibitor to treat type 2 diabetes, a fluorogenic kinetic analysis for DPP4 enzymatic activity using Gly-Pro-Aminomethylcoumarin (AMC) as a substrate was optimized and validated for recombinant DPP4 and human plasma samples. The sensitivity, calibration curve, detection range, accuracy, precision, recovery efficiency, Km constant, short/long-term stability, and stability after freezing-thawing cycles were analyzed. DPP4 enzymatic activity (mU/min) was measured as the initial velocity (Vo) of the enzymatic reaction over time. The sensitivity of the Vo value was 14,488 mU/min for recombinant DPP4 and 17,995 mU/min for human plasma samples. The dynamic ranges of the calibration curve were linear and reliable between 1.11 × 104-1.86 × 106 mU/min of the mean Vo value and in the DPP4 concentration range of 23.4-3,000 ng/mL. The assay's accuracy and precision met acceptance criteria for all samples. Plasma DPP4 was stable under various storage temperatures, even after three freeze-thaw cycles. Our optimized, validated bioanalytic method for measuring DPP4 activity in plasma samples was successfully employed to evaluate the effect of evogliptin (DA-1229) tartrate, which irreversibly and dose-dependently inhibits DPP4 enzymatic activity, without the dilution effect of human plasma samples and irrespective of the co-treated metformin.


Assuntos
Dipeptidil Peptidase 4/sangue , Ensaios Enzimáticos/métodos , Espectrometria de Fluorescência/métodos , Calibragem , Cumarínicos/metabolismo , Dipeptidil Peptidase 4/análise , Inibidores da Dipeptidil Peptidase IV/administração & dosagem , Inibidores da Dipeptidil Peptidase IV/metabolismo , Inibidores da Dipeptidil Peptidase IV/farmacologia , Humanos , Cinética , Limite de Detecção , Piperazinas/administração & dosagem , Piperazinas/metabolismo , Piperazinas/farmacologia , Estabilidade Proteica
2.
Acta Crystallogr Sect E Struct Rep Online ; 67(Pt 1): m85, 2010 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-21522601

RESUMO

In the title compound, [Cu(NO(3))(2)(C(15)H(19)N(3)O)], the Cu(II) ion is coordinated by the N atoms of the tetra-dentate 3-[bis-(2-pyridyl-meth-yl)amino]-propanol ligand and two O atoms from two monodentate nitrate anions, resulting in a distorted square-pyramidal environment. An inter-molecular O-H⋯O hydrogen-bonding inter-action between the free hy-droxy group of the ligand and a nitrate O atom of an adjacent complex unit, gives a chain structure which extends across the (101) planes.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...